Robert Eugene Watson - Net Worth and Insider Trading

Robert Eugene Watson Net Worth

The estimated net worth of Robert Eugene Watson is at least $76,720 dollars as of 2024-04-19. Robert Eugene Watson is the President & CEO of Streamline Health Solutions Inc and owns about 210,798 shares of Streamline Health Solutions Inc (STRM) stock worth over $69,985. Robert Eugene Watson is also the Director of CEL-SCI Corp and owns about 4,431 shares of CEL-SCI Corp (CVM) stock worth over $6,736. Details can be seen in Robert Eugene Watson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert Eugene Watson has not made any transactions after 2021-07-06 and currently still holds the listed stock(s).

Transaction Summary of Robert Eugene Watson

To

Robert Eugene Watson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Eugene Watson owns 2 companies in total, including CEL-SCI Corp (CVM) , and Streamline Health Solutions Inc (STRM) .

Click here to see the complete history of Robert Eugene Watson’s form 4 insider trades.

Insider Ownership Summary of Robert Eugene Watson

Ticker Comapny Transaction Date Type of Owner
CVM CEL-SCI Corp 2022-06-13 director
STRM Streamline Health Solutions Inc 2014-09-19 director & President & CEO

Robert Eugene Watson Latest Holdings Summary

Robert Eugene Watson currently owns a total of 2 stocks. Among these stocks, Robert Eugene Watson owns 210,798 shares of Streamline Health Solutions Inc (STRM) as of September 19, 2014, with a value of $69,985 and a weighting of 91.22%. Robert Eugene Watson also owns 4,431 shares of CEL-SCI Corp (CVM) as of July 6, 2021, with a value of $6,736 and a weighting of 8.78%.

Latest Holdings of Robert Eugene Watson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
STRM Streamline Health Solutions Inc 2014-09-19 210,798 0.33 69,985
CVM CEL-SCI Corp 2021-07-06 4,431 1.52 6,736

Holding Weightings of Robert Eugene Watson


Robert Eugene Watson Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Eugene Watson has made a total of 0 transactions in Streamline Health Solutions Inc (STRM) over the past 5 years. The most-recent trade in Streamline Health Solutions Inc is the acquisition of 5,000 shares on September 19, 2014, which cost Robert Eugene Watson around $19,600.

According to the SEC Form 4 filings, Robert Eugene Watson has made a total of 3 transactions in CEL-SCI Corp (CVM) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in CEL-SCI Corp is the acquisition of 1,250 shares on July 6, 2021, which cost Robert Eugene Watson around $10,000.

Insider Trading History of Robert Eugene Watson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Eugene Watson Trading Performance

GuruFocus tracks the stock performance after each of Robert Eugene Watson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Eugene Watson is 17.15%. GuruFocus also compares Robert Eugene Watson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Eugene Watson within 3 months outperforms 9 times out of 11 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert Eugene Watson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert Eugene Watson

Average Return

25.98%

Average return per transaction

Outperforming Transactions

45%

5 out of 11 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.18 17.15 22.35 25.98 0.26 -13.06
Relative Return to S&P 500(%) 2.78 14.12 15.44 15.1 -10.9 -23.89

Robert Eugene Watson Ownership Network

Ownership Network List of Robert Eugene Watson

No Data

Ownership Network Relation of Robert Eugene Watson


Robert Eugene Watson Owned Company Details

What does CEL-SCI Corp do?

Who are the key executives at CEL-SCI Corp?

Robert Eugene Watson is the director of CEL-SCI Corp. Other key executives at CEL-SCI Corp include Senior Vice President John Cipriano , Chief Scientific Officer Eyal Talor , and director & Chief Executive Officer Geert R Kersten .

CEL-SCI Corp (CVM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CEL-SCI Corp (CVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CEL-SCI Corp (CVM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CEL-SCI Corp (CVM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CEL-SCI Corp Insider Transactions

No Available Data

Robert Eugene Watson Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Eugene Watson. You might contact Robert Eugene Watson via mailing address: 245 N. Highland Ave Ne, Suite 230-296, Atlanta Ga 30307.

Discussions on Robert Eugene Watson

No discussions yet.